Solara Active Pharma Sciences DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Virtual Booth

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 71 News #PharmaBuzz

media
Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
71 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

195 All APIs, 102 USDMF, 31 CEP/COS, 5 JDMF, 73 EU WC, 91 KDMF, 29 NDC API, 63 Listed APIs

195 All APIs
102 USDMF
31 CEP/COS
5 JDMF
73 EU WC
91 KDMF
29 NDC API
63 Listed APIs

SERVICES

API Manufacturing, Analytical, API & Drug Product Development

pharmaServices
API Manufacturing
Analytical
- 2 Analytical Method Development
API & Drug Product Development
- 2 Preformulation & Material Science
- 6 API Development

INSPECTIONS & REGISTRATIONS

19 FDA, 7 GDUFA

inspections
19 FDA
7 GDUFA

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value based products while maintaining focus on the customer needs. We have 140+ scie...

CPhI ChinaCPhI China

Not Confirmed

Not Confirmed

24-26 June, 2025

SNIEC, Shanghai, China
Pharma SummitPharma Summit

Not Confirmed

Not Confirmed

23-24 June, 2025

Zurich, Switzerland
Pharmaceutical Science...Pharmaceutical Sciences

Not Confirmed

Not Confirmed

23-24 June, 2025

Paris, France

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

Country

India

Address

3rd & 4th Floor, Batra Centre, No.28, Sardar Patel Road, Guindy, Chennai – 6...

Telephone

+91 44 4344 6700

enquiries@pharmacompass.com

Website

https://solara.co.in/

https://www.linkedin.com/company/solara-active-pharma-sciences

YouTube

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]

Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

Impressions: 1208

VLOG #PharmaReel

[Sponsored by another company]

Providing RSMs & API to Global Pharma Companies

This PharmaReel showcases Allsino Pharmaceutical, a company that provides GMP-certified RSMs and APIs to global pharma companies, specializing in peptides, oligonucleotides, and small molecule CDMO services. Allsino has a presence in the US, EU, China and Japan.

Impressions: 823

DATA COMPILATION #PharmaFlow

[Sponsored by another company]

J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

The pharmaceutical industry has witnessed a wave of mergers, acquisitions, and strategic partnerships so far in the first half (H1) of 2025, with deal values exceeding US$ 170 billion.PharmaCompass’ data shows oncology alone accounted for nearly US$ 47 billion in deal value, followed by US$ 18 billion each in immunology and psychiatry, US$ 17 billion in nutrition/weight loss and US$ 7 billion in neurology.Pharma majors such as Johnson & Johnson and Bristol Myers Squibb led with two deals worth over US$ 10 billion each. Sanofi executed a series of deals in the immunology and neuro-inflammation space. And Eli Lilly stood out for its aggressive dealmaking, which spanned oncology, pain, RNA therapies, and AI-driven oligonucleotides. In all, it signed seven deals worth over US$ 1 billion each. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available)H1 records several mega deals as J&J buys Intra-Cellular, BMS ties up with BioNTech, Sanofi acquires BlueprintJohnson & Johnson dominated headlines with its US$ 14.6 billion acquisition of Intra-Cellular Therapies in January 2025. This marks the largest biopharma deal since Novo Nordisk’s US$ 16.5 billion acquisition of Catalent in February 2024. This acquisition positions J&J as a formidable player in the neuroscience space. Bristol Myers Squibb entered into a US$ 11.1 billion partnership with BioNTech. The deal structure — US$ 3.5 billion in unconditional payments and up to US$ 7.6 billion in milestone payments — demonstrates BMS’ confidence in BNT327, a next-generation bispecific antibody in phase 3 trials for treating extensive stage small cell lung cancer and non-small cell lung cancer.Sanofi acquired Blueprint Medicines for US$ 9.5 billion in order to enhance its rare disease portfolio. The French drugmaker is also creating a comprehensive immunology portfolio. The company signed a US$ 1.9 billion deal for Dren Bio’s DR-0201 bispecific antibody for autoimmune diseases. Sanofi also acquired Vigil Neuroscience for US$ 470 million for its phase 2-ready Alzheimer’s disease candidate. Additionally, the drugmaker secured a US$ 1.84 billion global license agreement with Earendil Labs for two next-generation bispecific antibodies.Pfizer’s US$ 6.05 billion partnership with 3SBio provides it global licensing rights (excluding China) for SSGJ-707, a bispecific antibody currently undergoing multiple clinical trials in China for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Obesity gold rush sees Roche, AbbVie, Sciwind ink deals; Novo pledges over US$ 5 bn across three dealsThe obesity therapeutics market has triggered intense competition among pharmaceutical giants. Roche’s US$ 5.3 billion partnership with Zealand Pharma is focused on petrelintide, an amylin analog designed to preserve lean mass better than existing GLP-1-based treatments. The collaboration combines petrelintide with Roche’s dual GLP-1/GIP receptor agonist CT-388, creating a differentiated obesity treatment.Market leader Novo Nordisk has promised over US$ 5 billion across three major obesity deals in 2025. The US$ 2.2 billion Septerna collaboration targets oral small molecule medicines for obesity and cardiometabolic diseases.Novo signed a separate US$ 2 billion agreement with China’s United Biotechnology for UBT251, a triple agonist for GLP-1, GIP, and glucagon receptors in phase 2 clinical development for obesity, type 2 diabetes, and other diseases. The company’s third major deal, a US$ 1 billion partnership with Lexicon Pharmaceuticals, provides it access to LX9851, a molecule in preclinical development for obesity and associated metabolic disorders.Sciwind Biosciences secured a US$ 2.5 billion global licensing and collaboration agreement with Verdiva Bio Limited for the global development and commercialization of a portfolio of metabolic diseases therapies. AbbVie entered the amylin arena through its US$ 2.2 billion Gubra partnership for GUB014295, a candidate in phase 1 trials for treating obesity. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Molecular glue degraders draw investments; Lilly signs seven deals over US$ 1 billion eachMolecular glue degraders have emerged as a transformative therapeutic modality, attracting significant investment across multiple partnerships. AbbVie’s US$ 1.64 billion collaboration with Neomorph leverages the biotech’s leading molecular glue discovery platform for oncology and immunology applications.Genentech’s potential US$ 2.1 billion partnership with Orionis Biosciences focuses on small-molecule monovalent glue medicines for novel and challenging oncology targets. This is the second partnership between the two companies, following their initial 2023 collaboration.Eli Lilly has collaborated with Magnet Biomedicine, utilizing Magnet’s TrueGlue discovery platform for oncology applications. The deal could be worth up to US$ 1.3 billion.Eli Lilly has emerged as one of 2025’s most active dealmakers, with approximately seven deals exceeding US$ 1 billion each. The company’s US$ 2.5 billion Scorpion Therapeutics acquisition provides access to STX-478, an experimental oral therapy in early-stage trials for breast cancer and advanced solid tumors, potentially addressing 30 to 40 percent of hormone-positive breast cancer patients.On June 17, Lilly announced the acquisition of gene-editing startup Verve Therapeutics for US$ 1.3 billion. Lilly’s US$ 1 billion SiteOne acquisition announced in May brings STC-004, a phase 2-ready non-opioid chronic pain treatment to its pipeline. Other partnerships announced by Lilly include a US$ 1.4 billion capsid licensing deal with Sangamo for central nervous system disease genomic medicines and a US$ 1.3 billion collaboration with South Korean company Rznomics for RNA-based hearing loss treatments. Lilly has also strengthened its oligonucleotide pipeline through a potential US$ 1 billion collaboration with Creyon Bio for AI-designed oligonucleotide therapies targeting RNA. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Merck KGaA acquires SpringWorks for US$ 3.9 bn; Novartis buys out Anthos for US$ 3.1 bnAstraZeneca signed a US$ 5.3 billion AI-led research agreement with China’s CSPC Pharmaceuticals Group to advance the discovery of novel oral candidates for immunological diseases. Merck KGaA acquired SpringWorks for US$ 3.9 billion in April, which gave it access to two FDA-approved therapies — Ogsiveo (nirogacestat), the first and only approved therapy for adult patients with progressing desmoid tumors requiring systemic treatment, and Gomekli (mirdametinib), the first and only FDA-approved therapy for adults and children with neurofibromatosis type 1-associated plexiform neurofibromas.Novartis’ US$ 3.1 billion Anthos Therapeutics acquisition centered around abelacimab, a potential first-in-class monoclonal antibody currently in three phase 3 studies for stroke and systemic embolism prevention in atrial fibrillation patients.GSK’s US$ 2 billion acquisition of Boston Pharmaceuticals’ efimosfermin targets steatotic liver disease (fatty liver disease). The medicine is also in clinical development for MASH treatment. GSK’s second major deal involved the US$ 1.15 billion acquisition of US biotech IDRx, strengthening its gastrointestinal cancer portfolio.The pharma industry also drew some private equity interest as Bain Capital acquired Japan’s Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group for US$ 3.3 billion. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Our viewDespite an uncertain geopolitical environment, the year has seen a surge in M&As and dealmaking in the first half of 2025. However, a sizable chunk of the acquisitions were bolt-on transactions, indicating that companies are not ready to take on risks, and are buying out smaller players who strategically fit into their operations. Going forward, there are indications that M&A activity will stay strong throughout 2025.

Impressions: 2456

NEWS #PharmaBuzz

Solara Active Pharma Sciences reports Rs. 2.10 Cr Q4 FY25 loss

18 May 2025

// INDPHARMAPOST

Solara Active Pharma reports profit of Rs 8.09 cr in Dec quarter

24 Jan 2025

// BUSINESS STD

Solara Active Pharma Sciences Ltd Surges 2.77%

07 Jan 2025

// BUSINESS STD

Solara Active Pharma Reports Q2 FY25 Net Profit at Rs. 8.01 Cr

23 Oct 2024

// INDPHARMAPOST

Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr

23 Jul 2024

// INDIANPHARMAPOST

US FDA inspects Vishakhapatnam facility of Solara Active Pharma

20 May 2024

// ECONOMICTIMES

ALL APIs

Click the button for full data set

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

Only 10 entries up to this point, click to access all

LISTED APIs

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Services

Upload your portfolio for free, ask us

API Manufacturing

Click here to discover the service providers for API Manufacturing

Scale Up

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Hydrogenation

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Clinical Supply

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Protein / Peptide

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Contract Manufacturing

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Custom Synthesis & Manufacturing

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Analytical

Click here to discover the service providers for Analytical

Analytical Method Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API & Drug Product Development

Click here to discover the service providers for API & Drug Product Development

Preformulation & Material Science

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Inspections and registrations

Upload your audits for free, ask us

FDA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

GDUFA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Contact Solara Active Pharma Sciences and get a quotation

Solara Active Pharma Sciences is a supplier offers 133 products (APIs, Excipients or Intermediates).

Find a price of Levetiracetam bulk with DMF, CEP, JDMF, WC offered by Solara Active Pharma Sciences

Find a price of Oseltamivir Phosphate bulk with DMF, CEP, JDMF, WC offered by Solara Active Pharma Sciences

Find a price of Aprepitant bulk with DMF, CEP, JDMF offered by Solara Active Pharma Sciences

Find a price of Bumetanide bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Buspirone Hydrochloride bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Celecoxib bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Colchicine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Dextromethorphan Hydrobromide bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Dipyridamole bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Etomidate bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Flecainide bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Gabapentin bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Hydralazine Hydrochloride bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Ibuprofen bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Lanthanum Carbonate bulk with DMF, JDMF, WC offered by Solara Active Pharma Sciences

Find a price of Mesalazine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Mesna bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Nizatidine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Olanzapine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Praziquantel bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Succinylcholine Chloride bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Sulfiram bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Venlafaxine Hydrochloride bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

Find a price of Brivaracetam bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Carisoprodol bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Cetirizine Dihydrochloride bulk with DMF, CEP offered by Solara Active Pharma Sciences

Find a price of Cinacalcet Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Colesevelam Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Cycloserine bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Edaravone bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Ethacrynic Acid bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Ibuprofen bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Ibuprofen Lysinate bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Ibuprofen Sodium bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Imiquimod bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Isradipine bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Ketoprofen bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Lurasidone Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Mefenamic Acid bulk with DMF, CEP offered by Solara Active Pharma Sciences

Find a price of Meprobamate bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Methohexital bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Methoxsalen bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Mirabegron bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Mycophenolate Mofetil bulk with DMF, CEP offered by Solara Active Pharma Sciences

Find a price of Mycophenolate Sodium bulk with DMF, CEP offered by Solara Active Pharma Sciences

Find a price of Obeticholic Acid bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Pitavastatin bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Posaconazole bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Rifaximin bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Rotigotine bulk with DMF, JDMF offered by Solara Active Pharma Sciences

Find a price of Safinamide Methanesulfonate bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Sevelamer Carbonate bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Sevelamer Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Tenofovir Disoproxil Fumarate bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Zileuton bulk with DMF, WC offered by Solara Active Pharma Sciences

Find a price of Quinapril bulk with WC offered by Solara Active Pharma Sciences

Find a price of Ranitidine bulk with WC offered by Solara Active Pharma Sciences

Find a price of Ranitidine Hydrochloride bulk with CEP offered by Solara Active Pharma Sciences

Find a price of Acitretin bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Acyclovir Sodium bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Albendazole bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Artemether bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Artesunate bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Atracurium Besylate bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Buspirone Hydrochloride bulk with WC offered by Solara Active Pharma Sciences

Find a price of Chlorphenesin bulk with WC offered by Solara Active Pharma Sciences

Find a price of Chlorpromazine Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Chlorthalidone bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Citicoline Sodium bulk with WC offered by Solara Active Pharma Sciences

Find a price of Clomipramine Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Colestipol bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Dabigatran Etexilate Mesylate bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Dextromethorphan bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Efinaconazole bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Ertapenem bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Erythromycin Ethyl Succinate bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Felbamate bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Fluocytosine bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Ibuprofen bulk with WC offered by Solara Active Pharma Sciences

Find a price of Ibuprofen Lysinate bulk with WC offered by Solara Active Pharma Sciences

Find a price of Ibuprofen Sodium bulk with WC offered by Solara Active Pharma Sciences

Find a price of Indomethacin Sodium bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Iron Sucrose bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Labetalol Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Lacidipine bulk with WC offered by Solara Active Pharma Sciences

Find a price of Lanthanum Carbonate bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Loratadine bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Lumefantrine bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Mebendazole bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Mesalazine bulk with WC offered by Solara Active Pharma Sciences

Find a price of Midazolam bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Milnacipran Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Nabumetone bulk with WC offered by Solara Active Pharma Sciences

Find a price of Naproxen bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Naproxen Sodium bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Pantoprazole Sodium bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Patiromer Sorbitex Calcium bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Pentoxifylline bulk with CEP offered by Solara Active Pharma Sciences

Find a price of Pregabalin bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Sapropterin Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Sodium Zirconium Cyclosilicate bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Succinylcholine Chloride bulk with WC offered by Solara Active Pharma Sciences

Find a price of Sugammadex Sodium bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Tioconazole bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Ursodeoxycholic Acid bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Venlafaxine Hydrochloride bulk with CEP offered by Solara Active Pharma Sciences

Find a price of Zidovudine bulk with DMF offered by Solara Active Pharma Sciences

Find a price of Mefenamic acid, Solara bulk with CEP offered by Solara Active Pharma Sciences

Find a price of Naproxen bulk offered by Solara Active Pharma Sciences

Find a price of Naproxen Sodium bulk offered by Solara Active Pharma Sciences

Find a price of Ranitidine Hydrochloride bulk offered by Solara Active Pharma Sciences

Find a price of Sulfasalazine bulk offered by Solara Active Pharma Sciences

Find a price of Carbidopa bulk offered by Solara Active Pharma Sciences

Find a price of Choline Chloride bulk offered by Solara Active Pharma Sciences

Find a price of Cinacalcet Hydrochloride bulk offered by Solara Active Pharma Sciences

Find a price of Edoxaban Tosylate bulk offered by Solara Active Pharma Sciences

Find a price of Etilevodopa bulk offered by Solara Active Pharma Sciences

Find a price of Favipiravir bulk offered by Solara Active Pharma Sciences

Find a price of Gabapentin bulk offered by Solara Active Pharma Sciences

Find a price of Ibuprofen bulk offered by Solara Active Pharma Sciences

Find a price of Ibuprofen Sodium bulk offered by Solara Active Pharma Sciences

Find a price of Iron Sucrose bulk offered by Solara Active Pharma Sciences

Find a price of Levetiracetam bulk offered by Solara Active Pharma Sciences

Find a price of Loxoprofen Sodium bulk offered by Solara Active Pharma Sciences

Find a price of Migalastat bulk offered by Solara Active Pharma Sciences

Find a price of Nizatidine bulk offered by Solara Active Pharma Sciences

Find a price of Olanzapine bulk offered by Solara Active Pharma Sciences

Find a price of Oseltamivir Phosphate bulk offered by Solara Active Pharma Sciences

Find a price of Patiromer bulk offered by Solara Active Pharma Sciences

Find a price of Pitavastatin bulk offered by Solara Active Pharma Sciences

Find a price of Sertraline Hydrochloride bulk offered by Solara Active Pharma Sciences

Find a price of Sevelamer Carbonate bulk offered by Solara Active Pharma Sciences

Find a price of Tranexamic Acid bulk offered by Solara Active Pharma Sciences

Company profile for Solara Active Pharma Sciences